(CIRB) A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (PH II-R) and Chemoradiation (PH III) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma
Cancer - Pancreas
Erlotinib, Gemcitabine, Gemzar, OSI-774, Tarceva
Chemotherapy multiple agents systemic, Chemotherapy single agent systemic
For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email email@example.com.